Clinical Trial Update: Phase I, Open-Label, Dose-Escalation Study of a Human Monoclonal Antibody, VRC-HIVMAB091-00-AB (N6LS), Administered Intravenously or Subcutaneously With or Without Recombinant Human Hyaluronidase PH20 (rHuPH20) [Phase 1]

View source ↗

Summary

Phase I open-label dose-escalation trial of a human monoclonal antibody (VRC-HIVMAB091-00-AB, N6LS) administered IV or subcutaneously with or without rHuPH20 fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• VRC-HIVMAB091-00-AB (N6LS) (VRC-HIVMAB091-00-AB)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Antibodies | Phase 1 | Status: COMPLETED | Results posted: 2023-09-21